Industry
Medical - Devices
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
Loading...
Open
3.75
Mkt cap
7.4M
Volume
1K
High
3.75
P/E Ratio
-0.80
52-wk high
4.73
Low
3.63
Div yield
N/A
52-wk low
2.66
Portfolio Pulse from
November 06, 2024 | 8:00 pm
Portfolio Pulse from Benzinga Newsdesk
August 13, 2024 | 6:49 pm
Portfolio Pulse from Benzinga Newsdesk
August 06, 2024 | 11:09 am
Portfolio Pulse from Benzinga Newsdesk
May 15, 2024 | 8:07 pm
Portfolio Pulse from Benzinga Newsdesk
May 15, 2024 | 8:03 pm
Portfolio Pulse from Benzinga Newsdesk
April 19, 2024 | 12:01 pm
Portfolio Pulse from Benzinga Newsdesk
March 14, 2024 | 1:01 pm
Portfolio Pulse from Benzinga Newsdesk
March 13, 2024 | 1:08 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.